Literature DB >> 8635661

Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians.

H Inoue1, J Ferrer, C M Welling, S C Elbein, M Hoffman, R Mayorga, M Warren-Perry, Y Zhang, H Millns, R Turner, M Province, J Bryan, M A Permutt, L Aguilar-Bryan.   

Abstract

NIDDM is a common heterogeneous disorder, the genetic basis of which has yet to be determined. The sulfonylurea receptor (SUR) gene, now known to encode an integral component of the pancreatic beta-cell ATP-sensitive potassium channel, IKATP, was investigated as a logical candidate for this disorder. The two nucleotide-binding fold (NBF) regions of SUR are known to be critical for normal glucose regulation of insulin secretion. Thus, single-strand conformational polymorphism analysis was used to find sequence changes in the two NBF regions of the SUR gene in 35 NIDDM patients. Eight variants were found; and three were evaluated in two Northern European white populations (Utah and the U.K.): 1) a missense mutation in exon 7 (S1370A) was found with equal frequency in patients (n = 223) and control subjects (n = 322); 2) an ACC-->ACT silent variant in exon 22 (T761T) was more common in patients than in control subjects (allele frequencies 0.07 vs. 0.02, P = 0.0008, odds ratio (OR) 3.01, 95% CI 1.54-5.87); and 3) an intronic t-->c change located at position -3 of the exon 24 splice acceptor site was also more common in patients than in control subjects (0.62 vs. 0.46, P < 0.0001, OR 1.91, 95% Cl 1.50-2.44). The combined genotypes of exon 22 C/T or T/T and intron 24 -3c/-3c occurred in 8.9% of patients and 0.5% of control subjects (P < 0.0001, OR 21.5, 95% CI 2.91-159.6). These results suggest that defects at the SUR locus may be a major contributor to the inherited basis of NIDDM in Northern European Caucasians.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8635661     DOI: 10.2337/diab.45.6.825

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  20 in total

Review 1.  The genetics of type 2 diabetes.

Authors:  M McCarthy; S Menzel
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

Review 2.  Candidate genes for type 2 diabetes.

Authors:  Hemang Parikh; Leif Groop
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 3.  Genetic epidemiology of diabetes.

Authors:  M Alan Permutt; Jonathon Wasson; Nancy Cox
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

4.  The Genetic Basis of Type 2 Diabetes.

Authors:  Swapan Kumar Das; Steven C Elbein
Journal:  Cellscience       Date:  2006-04-30

5.  Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans.

Authors:  R Duggirala; J Blangero; L Almasy; T D Dyer; K L Williams; R J Leach; P O'Connell; M P Stern
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

Review 6.  Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications.

Authors:  R David G Leslie; Robert M Cohen
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

7.  Sequence variations in the human Kir6.2 gene, a subunit of the beta-cell ATP-sensitive K-channel: no association with NIDDM in while Caucasian subjects or evidence of abnormal function when expressed in vitro.

Authors:  H Sakura; N Wat; V Horton; H Millns; R C Turner; F M Ashcroft
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

8.  Effect of genetic polymorphisms on the development of secondary failure to sulfonylurea in egyptian patients with type 2 diabetes.

Authors:  Alaa E El-Sisi; Sahar K Hegazy; Shereen S Metwally; Alaa M Wafa; Naglaa A Dawood
Journal:  Ther Adv Endocrinol Metab       Date:  2011-08       Impact factor: 3.565

Review 9.  Channeling dysglycemia: ion-channel variations perturbing glucose homeostasis.

Authors:  Jerod Scott Denton; David Aaron Jacobson
Journal:  Trends Endocrinol Metab       Date:  2011-11-29       Impact factor: 12.015

10.  Pharmacogenetics of Anti-Diabetes Drugs.

Authors:  Johanna K Distefano; Richard M Watanabe
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.